000 01336nam a2200349 i 4500
999 _c12586
_d12586
001 23732143
005 20210224095305.0
008 910425s1991 nyua b 001 0 eng c
010 _a91-16479
020 _a0824785053 (alk. paper)
035 _a4959446
040 _aDNLM/DLC
_cDLC
_dOSU
_erda
050 _aRS201.L53
_bL56 1991
050 0 0 _aRS201.L53
_bL56 1991
060 _aW1 TA579 v. 5
_aQV 785 L764
082 0 4 _222
_a615.19
_bL.
245 0 0 _aLipoproteins as carriers of pharmacological agents /
_cedited by J. Michael Shaw, sterling drug Inc., Malvern, Pennsylvania
264 1 _aNew York :
_bMarcel Dekker Inc.,
_c[1991]
264 4 _c©1991
300 _axi, 404 pages :
_billustrations ;
_c24 cm
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
490 1 _aTargeted diagnosis and therapy;
_v5
504 _aIncludes bibliographical references and index
520 _a Explores endogenous lipoprotein particles and their interaction with pharmacological agents. This title covers topics such as receptor-dependent interactions of lipoproteins with tissues and cell
650 0 _aLipoprotein drug carriers
700 1 _aShaw, J. Michael,
_d1944-,
_eeditor.
830 0 _aTargeted diagnosis and therapy
_v5
942 _2ddc
_cBK